Search Results - "Magdeleyns, Elke"
-
1
Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease
Published in Maturitas (01-02-2014)“…Abstract Objectives Vitamin K plays a pivotal role in the synthesis of Matrix Gla protein (MGP), a calcification inhibitor in vascular tissue. Vascular…”
Get full text
Journal Article -
2
Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults
Published in The Journal of nutrition (01-08-2011)“…Matrix Gla protein (MGP) is a calcification inhibitor in vascular tissue that must be carboxylated by vitamin K to function. Evidence suggests circulating…”
Get more information
Journal Article -
3
The Circulating Inactive Form of Matrix Gla Protein Is a Surrogate Marker for Vascular Calcification in Chronic Kidney Disease: A Preliminary Report
Published in Clinical journal of the American Society of Nephrology (01-04-2010)“…Vitamin K-dependent matrix Gla protein (MGP) acts as a calcification inhibitor in vitro and in vivo. The present study was performed to (1) determine plasma…”
Get full text
Journal Article -
4
Vitamin K intake and status are low in hemodialysis patients
Published in Kidney international (01-09-2012)“…Vitamin K is essential for the activity of γ-carboxyglutamate (Gla)-proteins including matrix Gla28 protein and osteocalcin; an inhibitor of vascular…”
Get more information
Journal Article -
5
Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species
Published in Thrombosis and haemostasis (01-10-2010)“…Matrix γ-carboxyglutamate (Gla) protein (MGP) is an important local inhibitor of vascular calcification, which can undergo two post-translational…”
Get more information
Journal Article -
6
Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women
Published in The Journal of nutritional biochemistry (01-04-2013)“…Matrix Gla protein (MGP) is a vitamin K-dependent protein and an inhibitor of vascular calcification. Vitamin K is required for the carboxylation of MGP and…”
Get full text
Journal Article -
7
Circulating Nonphosphorylated Carboxylated Matrix Gla Protein Predicts Survival in ESRD
Published in Journal of the American Society of Nephrology (01-02-2011)“…The mechanisms for vascular calcification and its associated cardiovascular mortality in patients with ESRD are not completely understood. Dialysis patients…”
Get full text
Journal Article -
8
Matrix Gla Protein Species and Risk of Cardiovascular Events in Type 2 Diabetic Patients
Published in Diabetes care (01-11-2013)“…To investigate the relationship of circulating matrix Gla protein (MGP) species with incident cardiovascular disease (CVD) or coronary heart disease (CHD) in…”
Get full text
Journal Article -
9
Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects
Published in British journal of nutrition (14-11-2012)“…Vitamin K is required for the carboxylation of Gla-proteins in the liver (coagulation factors) and extra-hepatic tissues, such as bone (osteocalcin, OC), and…”
Get full text
Journal Article -
10
Effects of storage‐induced platelet microparticles on the initiation and propagation phase of blood coagulation
Published in British journal of haematology (01-08-2006)“…Summary Platelets shed microparticles, which support haemostasis via adherence to the damaged vasculature and by promoting blood coagulation. We investigated…”
Get full text
Journal Article -
11
Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women
Published in International journal of cardiology (15-10-2013)Get full text
Journal Article -
12
Factor Va, bound to microparticles released during platelet storage, is resistant to inactivation by activated protein C
Published in Transfusion (Philadelphia, Pa.) (01-10-2007)“…BACKGROUND: Microparticles (MPs) support coagulation and can be helpful in restoring the hemostatic system in thrombocytopenic patients. The anticoagulant…”
Get full text
Journal Article -
13
Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial
Published in American journal of kidney diseases (01-02-2012)“…Background Vascular calcification is a predictor of cardiovascular morbidity and mortality. Hemodialysis patients experience severe vascular calcifications…”
Get full text
Journal Article -
14
Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Published in Haematologica (Roma) (01-10-2003)“…Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. BACKGROUND AND OBJECTIVES:…”
Get full text
Journal Article -
15
Effect of Vitamin K 2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial
Published in American journal of kidney diseases (01-02-2012)“…Vascular calcification is a predictor of cardiovascular morbidity and mortality. Hemodialysis patients experience severe vascular calcifications. Matrix Gla…”
Get full text
Journal Article -
16
Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation
Published in Kidney international (01-08-2014)“…In chronic kidney disease, vitamin K-dependent proteins, including the calcification inhibitor matrix Gla protein, are largely uncarboxylated indicating that…”
Get more information
Journal Article -
17
Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein
Published in Cardiovascular diabetology (24-04-2014)“…Matrix Gla protein (MGP) is an important inhibitor of calcification. The objective of the present study of patients with type 2 diabetes and normal or slightly…”
Get full text
Journal Article -
18
Abstract P397: Circulating Species of Matrix Gla Protein and the Risk of Vascular Calcification in Healthy Women
Published in Circulation (New York, N.Y.) (26-03-2013)“…Abstract only Background: Matrix Gla protein (MGP) is an inhibitor of vascular calcification that requires vitamin K for its carboxylation. Circulating MGP…”
Get full text
Journal Article -
19
Abstract P186: Circulating Desphospho-uncarboxylated Matrix Gla Protein and the Risk of Coronary Heart Disease and Stroke
Published in Circulation (New York, N.Y.) (25-03-2014)“…Abstract only Background: Matrix Gla protein (MGP) is a vitamin K dependent protein and a potent inhibitor of vascular calcification. Desphospho-uncarboxylated…”
Get full text
Journal Article -
20
Abstract P071: The Effect of Menaquinone -7 Supplementation on Circulating Species of Matrix-Gla Protein
Published in Circulation (New York, N.Y.) (13-03-2012)“…Abstract only Background: Menaquinones intake is associated with a reduced risk of coronary calcification and coronary heart disease. This association may be…”
Get full text
Journal Article